Understanding and Easing Growing Pains Growing pains – we’ve all heard of them. If you think back to childhood or recall ...
While the labour market may be tight for the pharmaceutical industry, organisations can get ahead of growing pains by prioritising ... 2025 marks a pivotal moment for drug developers and ...
In December 2017, the US Food & Drug Administration (FDA) approved Luxturna from Spark Therapeutics — the first gene therapy to win market approval in the US. Several other gene therapy programs ...